If you start taking the new weight-loss medications, be ready to stay with it for a long time, says Dr V Mohan, Chennai-based ...

With one in eight adults taking drugs like Ozempic and Mounjaro, emerging evidence shows that the medication has potential to ...

On June 16, the Charles sheriff’s office was contacted by the Office of Controlled Substance Administration of Maryland in reference to a fraudulent prescription scheme that was occurring at Southern ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the ...

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways ...

A meta-analysis found that antiobesity drugs — with the exception of coagonists — did not reduce the risk for overall or site ...

Navigate insurance coverage for GLP-1 weight loss medications like Wegovy and Zepbound by learning about costs, eligibility requirements, prior authorizations, and appeals to maximize your chances of ...

The Global Anti-Obesity Drug Market is estimated to be valued at USD 25.87 Bn in 2025 and is expected to reach USD 82.55 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 18.01% from 2025 ...